수의용 항감염제 시장 보고서(2026년)
Veterinary Anti-infectives Global Market Report 2026
상품코드 : 1938708
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,777,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,796,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,815,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

수의용 항감염제 시장의 규모는 최근 현저한 성장을 달성하고 있습니다. 2025년 60억 2,000만 달러에서 2026년에는 65억 9,000만 달러로, CAGR 9.6%로 확대할 전망입니다. 지난 수년간의 성장세는 가축 질병 증가 추세, 반려동물 증가, 항생제에 대한 전통적 의존도, 수의학에 대한 인식 증가, 아시아태평양의 동물병원 확대 등이 주요 요인으로 꼽힙니다.

수의용 항감염제 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 95억 3,000만 달러에 달하며, CAGR은 9.7%에 달할 전망입니다. 예측 기간 중의 성장은 정밀 수의학 의약품에 대한 수요 증가, 항바이러스제 및 항진균제의 채택 확대, 예방 의료에 대한 관심 증가, 동물병원 및 약국 확대, 면역 조절제 및 첨단 소독제 개발 등에 기인할 것으로 보입니다. 예측 기간의 주요 동향으로는 항생제 및 항균제 사용 증가, 백신 및 항바이러스제 도입 확대, 동물 질병 예방에 대한 인식 개선, 반려동물 헬스케어 시장 확대, 외용 및 전신 항진균제 치료 수요 증가 등을 꼽을 수 있습니다.

반려동물 사육 수 증가는 향후 동물용 항감염제 시장 확대를 견인할 것으로 예측됩니다. 반려동물 사육이란 개나 고양이 등 가축을 가정의 반려동물로 키우는 것을 말합니다. 젊은 층에서 반려동물을 가족의 일원으로 여기는 비율이 증가하고 있으며, 반려동물을 동반자로서의 존재감과 충성심, 외로움의 감소를 목적으로 반려동물을 기르는 사람들도 늘어나면서 반려동물 양육 인구가 증가하는 추세입니다. 동물용 항감염제는 동물의 감염병을 예방 및 치료하여 반려동물 사육을 지원하고, 반려동물의 건강 유지와 반려동물과 보호자 모두에게 질병 전파 위험을 줄이는 데 기여합니다. 예를 들어 미국 비정부기구 '쉘터 애니멀스 카운트'에 따르면 2023년 전국적으로 2022년 동기 대비 약 17만 7천 마리의 개와 고양이가 새롭게 동물보호소에 입소했습니다. 따라서 반려동물 사육 수 증가는 수의용 항감염제 시장 수요를 견인하고 있습니다.

수의용 항감염제 시장에서 사업을 운영하는 주요 기업은 시장에서의 지위를 유지 및 강화하기 위해 첨단 기술을 활용하고 있습니다. 첨단 기술에는 동물 전염병의 예방, 진단 및 치료를 개선하고 효과와 안전성을 향상시키는 혁신적인 툴와 방법이 포함됩니다. 예를 들어 2025년 5월 미국 기반의 E-Commerce 및 약국 서비스 프로바이더인 아마존닷컴(Amazon.com Inc.)은 미국 수의학 기술 및 약국 플랫폼인 Strategic Pharmaceutical Solutions Inc. 반려동물용 처방약 제공을 확대했습니다. 이 구상을 통해 고객은 수의사가 승인한 항감염제 및 기타 처방약을 온라인으로 주문할 수 있으며, 보통 2-6일 이내에 배송됩니다. 또한 디지털 결제 통합과 수의사 확인을 통해 처방전 갱신 승인 프로세스를 효율화했습니다. 이러한 접근 방식은 접근성을 확대하고 고객 참여를 향상시키지만, 임상 워크플로우 및 규제 요건과 신중하게 조화를 이루어야 합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

The term veterinary anti-infective encompasses a wide range of methods aimed at preventing and treating illnesses in animals. These products are utilized in veterinary medicine to promote the health and well-being of both livestock and pets, as well as to control disease outbreaks within animal populations.

The main types of drug classes in veterinary anti-infectives include antimicrobial agents, antiviral agents, antifungal agents, and others. Antimicrobial agents are substances, either natural or synthetic, that function by killing or inhibiting the growth of microorganisms such as bacteria, fungi, and algae. Various species, including livestock animals and companion animals, are involved in the administration of these drugs through oral, parenteral, and topical modes. Distribution channels for veterinary anti-infectives include veterinary hospitals, veterinary clinics, pharmacies, and other relevant outlets.

Tariffs have affected the veterinary anti-infectives market by increasing the cost of imported drugs, vaccines, and medical equipment, particularly in regions like north america and europe. Segments such as antimicrobial agents, antiviral agents, and antifungal agents are most impacted due to reliance on imported raw materials and formulations. Positive impacts include incentivizing domestic production, fostering local R&D in veterinary drugs, and encouraging innovation in cost-effective anti-infective solutions.

The veterinary anti-infectives market research report is one of a series of new reports from The Business Research Company that provides veterinary anti-infectives market statistics, including veterinary anti-infectives industry global market size, regional shares, competitors with a veterinary anti-infectives market share, detailed veterinary anti-infectives market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary anti-infectives industry. This veterinary anti-infectives market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary anti-infectives market size has grown strongly in recent years. It will grow from $6.02 billion in 2025 to $6.59 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to rising prevalence of livestock diseases, growing companion animal population, traditional reliance on antibiotics, increasing veterinary awareness, expansion of veterinary clinics in asia-pacific.

The veterinary anti-infectives market size is expected to see strong growth in the next few years. It will grow to $9.53 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rising demand for precision veterinary medicines, growing adoption of antiviral and antifungal agents, increasing focus on preventive healthcare, expansion of veterinary hospitals and pharmacies, development of immune modulators and advanced disinfectants. Major trends in the forecast period include increasing use of antibiotics and antimicrobial agents, rising adoption of vaccines and antiviral medications, growing awareness of animal disease prevention, expansion of companion animal healthcare market, rising demand for topical and systemic antifungal treatments.

The growth in pet ownership is expected to drive the expansion of the veterinary anti-infectives market going forward. Pet ownership refers to having a dog, cat, or other domestic animal as a household companion. Pet adoption is increasing as a growing share of the younger population considers pets to be part of the family, while others adopt pets for companionship, loyalty, and to reduce feelings of loneliness. Veterinary anti-infectives support pet ownership by preventing and treating infections in animals, helping maintain pet health and lowering the risk of disease transmission to both pets and owners. For example, in 2023, according to Shelter Animals Count, a US-based non-governmental organization, approximately 177,000 additional dogs and cats entered the animal sheltering system nationwide compared with the same period in 2022. Therefore, the rise in pet ownership is driving demand for the veterinary anti-infectives market.

Leading companies operating in the veterinary anti-infectives market are leveraging advanced technologies to maintain and strengthen their market position. Advanced technologies include innovative tools and methods that enhance the prevention, diagnosis, and treatment of animal infections, improving both effectiveness and safety. For instance, in May 2025, Amazon.com Inc., a US-based e-commerce and pharmacy services provider, expanded its pet prescription medication offerings through a partnership with Strategic Pharmaceutical Solutions Inc. (Vetsource), a US-based veterinary technology and pharmacy platform. This initiative enables customers to order veterinarian-approved anti-infectives and other prescriptions online, with delivery typically within two to six days, and streamlines refill approvals through digital checkout integration and veterinarian verification. This approach broadens access and improves customer engagement, while requiring careful alignment with clinical workflows and regulatory requirements.

In April 2024, Virbac S.A., a France-based supplier of veterinary pharmaceuticals, vaccines, anti-infectives, and animal health products for companion animals and livestock, acquired Sasaeah Pharmaceutical Co. Ltd. for an undisclosed amount. Through this acquisition, Virbac expanded its geographic presence and strengthened its veterinary anti-infectives and broader pharmaceutical portfolio, particularly within the cattle segment, by leveraging Sasaeah's established manufacturing and research and development capabilities in Japan and Vietnam. Sasaeah Pharmaceutical Co. Ltd. is a Japan-based provider of veterinary health products, including vaccines, anti-infectives, and pharmaceutical treatments across major animal species, reinforcing Virbac's competitive position in the global veterinary anti-infectives market.

Major companies operating in the veterinary anti-infectives market are Bayer AG, C. H. Boehringer Sohn AG & Co. KG, Ceva Sante Animale, Elanco Animal Health Incorporated, Zoetis Inc., Vetoquinol S. A., Merck & Co., Phibro Animal Health, Aspen Veterinary Resources Ltd., Bimeda Animal Health Limited, Dechra Pharmaceuticals Plc, Intervet International B. V., Oceanic Pharmachem Pvt. Ltd., Virbac Ltd., Indian Immunologicals Ltd. (IIL), Norbrook Laboratories Ltd., Ashish Life Science Pvt. Ltd., Kyoritsu Seiyaku Corporation, Tianjin Ringpu Bio-Technology Co. Ltd., HIPRA, Zydus Animal Health and Investments Limited, China Animal Husbandry Group, ZOOVETVARU Ltd., Magnum Veterinaaria Ltd., Inovet (V. M. D. nv/sa), Chanelle Pharmaceuticals Manufacturing Ltd., Huvepharma Inc., Veyx Pharma GmbH, Biovet Pvt. Ltd., Laboratorios Ovejero SA, Laboratorios Syva S. A.

North America was the largest region in the veterinary anti-infectives market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary anti-infectives market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary anti-infectives market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary anti-infectives market consists of revenues earned by entities by providing antibacterial that are used to prevent and treat animal diseases such as infections. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Anti-infectives Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses veterinary anti-infectives market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for veterinary anti-infectives ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary anti-infectives market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Veterinary Anti-infectives Market Characteristics

3. Veterinary Anti-infectives Market Supply Chain Analysis

4. Global Veterinary Anti-infectives Market Trends And Strategies

5. Veterinary Anti-infectives Market Analysis Of End Use Industries

6. Veterinary Anti-infectives Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Veterinary Anti-infectives Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Veterinary Anti-infectives Total Addressable Market (TAM) Analysis for the Market

9. Veterinary Anti-infectives Market Segmentation

10. Veterinary Anti-infectives Market Regional And Country Analysis

11. Asia-Pacific Veterinary Anti-infectives Market

12. China Veterinary Anti-infectives Market

13. India Veterinary Anti-infectives Market

14. Japan Veterinary Anti-infectives Market

15. Australia Veterinary Anti-infectives Market

16. Indonesia Veterinary Anti-infectives Market

17. South Korea Veterinary Anti-infectives Market

18. Taiwan Veterinary Anti-infectives Market

19. South East Asia Veterinary Anti-infectives Market

20. Western Europe Veterinary Anti-infectives Market

21. UK Veterinary Anti-infectives Market

22. Germany Veterinary Anti-infectives Market

23. France Veterinary Anti-infectives Market

24. Italy Veterinary Anti-infectives Market

25. Spain Veterinary Anti-infectives Market

26. Eastern Europe Veterinary Anti-infectives Market

27. Russia Veterinary Anti-infectives Market

28. North America Veterinary Anti-infectives Market

29. USA Veterinary Anti-infectives Market

30. Canada Veterinary Anti-infectives Market

31. South America Veterinary Anti-infectives Market

32. Brazil Veterinary Anti-infectives Market

33. Middle East Veterinary Anti-infectives Market

34. Africa Veterinary Anti-infectives Market

35. Veterinary Anti-infectives Market Regulatory and Investment Landscape

36. Veterinary Anti-infectives Market Competitive Landscape And Company Profiles

37. Veterinary Anti-infectives Market Other Major And Innovative Companies

38. Global Veterinary Anti-infectives Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Veterinary Anti-infectives Market

40. Veterinary Anti-infectives Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기